VAV1 and lung adenocarcinoma: Mutations in VAV1 identified in human lung adenocarcinoma also confer oncogenic activity that can be attributed to their enhanced Rho/Rac activity (Campbell et al., 2016; Shalom et al., 2018; Cai et al., 2019).